Drugs / meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)
meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02097849 | Feb 2015 → May 2016 | relapsing-remitting multiple sclerosis | Biogen | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02097849 ↗ |
| Modality | Vaccine | “meningococcal polysaccharide diphtheria conjugate vaccine, quadrivalent (MCV4)” NCT02097849 ↗ |
| Route | Intramuscular | “3 vaccinations on Day 1 intramuscularly in the specified order” NCT02097849 ↗ |